Lazard Asset Management LLC Biotechnology

Lazard Asset Management LLC

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
OCGN Ocugen, Inc.	$156M	$0 0.0% of portfolio	550	Q3 2024 Reduced 76.51%
PGEN Precigen, Inc.	$312M	$0 0.0% of portfolio	259	Q3 2024 Reduced 98.95%
PRQR Pro Qr Therapeutics N.V.	$103M	$0 0.0% of portfolio	103	Q3 2024 Reduced 62.68%
RGNX Regenxbio Inc.	$396M	$0 0.0% of portfolio	45	Q4 2024 Reduced 99.41%
RGLS Regulus Therapeutics Inc.	$40.4M	$0 0.0% of portfolio	122	Q2 2024 New
RCKT Rocket Pharmaceuticals, Inc.	$547M	$0 0.0% of portfolio	30	Q3 2024 Reduced 61.54%
SANA Sana Biotechnology, Inc.	$337M	$0 0.0% of portfolio	132	Q3 2024 Reduced 60.0%
SILO Silo Pharma, Inc.	$3.61M	$0 0.0% of portfolio	953	Q4 2024 Reduced 6.39%
STOK Stoke Therapeutics, Inc.	$385M	$0 0.0% of portfolio	58	Q3 2024 Reduced 72.77%
TSHA Taysha Gene Therapies, Inc.	$84.6M	$0 0.0% of portfolio	154	Q3 2024 Reduced 57.92%
TNYA Tenaya Therapeutics, Inc.	$19.9M	$0 0.0% of portfolio	77	Q3 2024 Reduced 64.52%
TCRX T Scan Therapeutics, Inc.	$30.7M	$0 0.0% of portfolio	70	Q3 2024 Reduced 60.23%
RARE Ultragenyx Pharmaceutical Inc.	$2.67B	$0 0.0% of portfolio	14	Q4 2024 Reduced 99.93%
QURE Uni Qure N.V.	$663M	$0 0.0% of portfolio	47	Q4 2024 Reduced 99.65%
VERV Verve Therapeutics, Inc.	$345M	$0 0.0% of portfolio	85	Q3 2024 Reduced 39.72%
VYGR Voyager Therapeutics, Inc.	$133M	$0 0.0% of portfolio	148	Q4 2024 Reduced 97.72%

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.